Pharmaceuticals Projects in Madhya Pradesh – Page 10
86 upcoming and ongoing pharmaceuticals projects in Madhya Pradesh worth ₹14,851 Cr, with investment, location, project stage and latest status. Last updated 08 Apr 2026.
Projects tracked
86
Total investment
₹14,851 Cr
Pre-project / Under construction
0 / 0
Added in the last 30 days
0
Latest pharmaceuticals projects in Madhya Pradesh
Showing 46–50 of 86
Project Work CommencedPharmaceuticals ProjectsUpdated
A notable company plans to invest in a new liquid ampoule and vial manufacturing project in Smart Industrial Park, Pithampur, Dhar, Madhya Pradesh. The project includes the production of liquid ampoules, vials, and other pharmaceutical products.
A pharma products manufacturing expansion project is being planned in Madhya Pradesh with an estimated cost of Rs. 50 million. The project aims to increase the manufacturing capacity of various pharmaceutical products, including capsules, dry powder, injections, and more. As of February 2022, the company has received consent from the state pollution control authorities to establish the project, which reflects its commitment to sustainable and ethical practices in its operations. The expansion is expected to enable the company to meet growing demand and strengthen its position in the pharmaceutical industry.
A new API & API intermediates manufacturing project in Sant Nagar, Ujjain, MP with a capacity of 94500 Kg/Y is estimated to cost Rs.240M. Consent from state pollution control authorities has been obtained as of Jan 2022.
A pharmaceutical company plans to expand tablet & capsule manufacturing in Dharampur, Baddi, Solan, Himachal Pradesh. The project will increase capacity from 1200M to 5700M tablets & from 44M to 62M capsules. Project cost is Rs.264mn. Approved by State Single Window Authority in August 2021, project work has commenced as of Jan 2022.
A pharmaceutical firm plans to produce over two million units of injectables in Dhar, Madhya Pradesh. The project is in the planning stage as of December 2021, and the company has filed the necessary memorandum in November 2021.